22nw, LP is an SEC-registered investment adviser based in Seattle, WA that reports managing 1 hedge fund on Form ADV. It reports $295.6 million in regulatory assets under management. Its private funds, of all types, hold $295.6 million in gross assets. Over a longer period they returned an estimated +61.6% from Q3 2024 to Q2 2026, compared with +43.9% for the S&P 500, based on 13F filings.
- Regulatory assets under management
- $295.6 millionForm ADV Item 5.F
- Gross assets of private funds
- $295.6 millionAll private fund types, Form ADV
- Hedge funds managed
- 11 private funds in total
- Employees
- 6Form ADV Item 5.A
- Registration
- SEC-registered adviserCRD 230788
- Latest Form ADV
- 03/13/2026Disciplinary disclosures: none reported
Estimated 13F portfolio performance
| Quarter | Est. 13F return | S&P 500 |
|---|---|---|
| Q2 2026 | +31.7% | +14.8% |
| Q4 2025 | -17.8% | +2.4% |
| Q3 2025 | +28.8% | +7.8% |
| Q2 2025 | +20.2% | +10.4% |
| Q1 2025 | -16.4% | -4.5% |
| Q4 2024 | +17.1% | +2.1% |
| Q3 2024 | -1.6% | +5.4% |
Estimate of the firm's disclosed long U.S. stock portfolio from its quarterly 13F filings, holding each quarter-end portfolio to the next quarter-end at prices implied by all 13F filers. It is a price return before dividends and fees, ignores shorts, options, bonds, cash and trading within the quarter, and is not the return of any fund. Disclosures
Largest disclosed holdings
- Insperity Inc$20.4 million
- Nektar Therapeutics$19.6 million
- Stoneridge Inc$18.1 million
- Fox Factory Hldg Corp$11.5 million
- Core Molding Technologies In$6.5 million
- Regenxbio Inc Com$5.9 million
- Culp Inc$5.8 million
- Rezolute Inc$4.3 million
- Unifi Inc$4.0 million
- Mineralys Therapeutics Inc$3.1 million
As of 2026-06-30, from 13F filing by 22nw, LP.
From SEC filings. Firm data comes from the SEC's Form ADV data as of Oct 2, 2026; performance estimates come from Form 13F. HedgeMountain has not verified this information, and it is not an offer, solicitation or recommendation. Full disclosures